Correlation Between Incyte and AstraZeneca PLC
Can any of the company-specific risk be diversified away by investing in both Incyte and AstraZeneca PLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Incyte and AstraZeneca PLC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Incyte and AstraZeneca PLC ADR, you can compare the effects of market volatilities on Incyte and AstraZeneca PLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Incyte with a short position of AstraZeneca PLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Incyte and AstraZeneca PLC.
Diversification Opportunities for Incyte and AstraZeneca PLC
-0.22 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Incyte and AstraZeneca is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding Incyte and AstraZeneca PLC ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AstraZeneca PLC ADR and Incyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Incyte are associated (or correlated) with AstraZeneca PLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AstraZeneca PLC ADR has no effect on the direction of Incyte i.e., Incyte and AstraZeneca PLC go up and down completely randomly.
Pair Corralation between Incyte and AstraZeneca PLC
Given the investment horizon of 90 days Incyte is expected to generate 1.96 times more return on investment than AstraZeneca PLC. However, Incyte is 1.96 times more volatile than AstraZeneca PLC ADR. It trades about 0.2 of its potential returns per unit of risk. AstraZeneca PLC ADR is currently generating about 0.24 per unit of risk. If you would invest 5,408 in Incyte on March 7, 2024 and sell it today you would earn a total of 449.00 from holding Incyte or generate 8.3% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 95.45% |
Values | Daily Returns |
Incyte vs. AstraZeneca PLC ADR
Performance |
Timeline |
Incyte |
AstraZeneca PLC ADR |
Incyte and AstraZeneca PLC Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Incyte and AstraZeneca PLC
The main advantage of trading using opposite Incyte and AstraZeneca PLC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Incyte position performs unexpectedly, AstraZeneca PLC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AstraZeneca PLC will offset losses from the drop in AstraZeneca PLC's long position.Incyte vs. Eyenovia | Incyte vs. Arrowhead Pharmaceuticals | Incyte vs. Krystal Biotech | Incyte vs. BioNTech SE |
AstraZeneca PLC vs. ABIVAX Socit Anonyme | AstraZeneca PLC vs. Franklin Strategic Mortgage | AstraZeneca PLC vs. Morningstar Unconstrained Allocation | AstraZeneca PLC vs. Via Renewables |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |